Log In
Print
BCIQ
Print
Print this Print this
 

ambroxol (EXR-202)

  Manage Alerts
Collapse Summary General Information
Company ExSAR Corporation
DescriptionBioavailable blood-brain barrier permeable small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today